Changes in the Laboratory Data for Cancer Patients Treated with Korean-medicine-based Inpatient Care

키워드

참고문헌 (36)

1. Lin WW., "A cytokine-mediated link between innate immunity, inflammation, and cancer", J Clin Invest, 117(5), pp.1175~1183 (2007)
2. Reynés G., "Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma", J Neurooncol, 102(1), pp.35~41 (2011)
3. Lwaleed BA., "Tissue factor : a critical role in inflammation and cancer", Biol Res Nurs, 9(2), pp.97~107 (2007)
4. Stadnisky MD., "Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity", Blood, 117(19), pp.5133~5141 (2011)
5. Fernandez PM., "Tissue factor and fibrin in tumor angiogenesis", Semin Thromb Hemost, 30(1), pp.31~44 (2004)
6. Buller HR., "Cancer and thrombosis : from molecular mechanisms to clinical presentations", J Thromb Haemost, 5, pp.246~254 (2007)
7. Palumbo JS., "Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination", Semin Thromb Hemost, 34(2), pp.154~160 (2008)
8. Rickles FR., "Tissue factor, thrombin, and cancer", Chest, 124(3 Suppl), pp.58~68 (2003)
9. Khorana AA., "Pancreatic cancer and thromboembolic disease", Lancet Oncol, 5(11), pp.655~663 (2004)
10. Liu L., "Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation", J Ethnopharmacol, 139(2), pp.381~387 (2012)
11. Liang JQ., "Anticoagulative effect and antiplatelet aggregation effect of combination of Hirudo and Tabanus on rat model of blood stasis syndrome", Zhong Yao Cai, 32(9), pp.1347~1350 (2009)
12. Ma H., "Effects of Yangyin Shengjin Decoction on hemorheological parameters and coagulation factors in model rabbits with syndrome of excessive heat consuming body fluid and blood stasis", Zhong Xi Yi Jie He Xue Bao, 3(1), pp.39~42 (2005)
13. Meng MB., "Meta-analysis : traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization", Explore(NY), 7(1), pp.37~43 (2011)
14. Liu Z., "Clinical observation of immunity for severe acute pancreatitis", Inflammation, 34(5), pp.426~431 (2011)
15. Zhao CL., "Effect of acupuncture on the activity of the peripheral blood T lymphocyte subsets and NK cells in patients with colorectal cancer liver metastasis", Zhongguo Zhen Jiu, 30(1), pp.10~12 (2010)
16. Oken MM., "Toxicity and response criteria of the Eastern Cooperative Oncology Group", Am J Clin Oncol, 5(6), pp.649~655 (1982)
17. Luo J., "Circulating lymphocyte subsets in patients with lung cancer and their prognostic value", Zhongguo Fei Ai Za Zhi, 14(8), pp.669~673 (2011)
18. Soygür T., "The prognostic value of peripheral blood lymphocyte subsets in patients with bladder carcinoma treated using neoadjuvant M-VEC chemotherapy", BJU Int, 84(9), pp.1069~1072 (1999)
19. Hus I., "CD3+", CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma, 2011, pp.49(1), 183~187
20. Plonquet A., "Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma", Ann Oncol, 18(7), pp.1209~1215 (2007)
21. Stewart DA., "The CD3-16+ 56+ NK cell count independently predicts autologous blood stem cell mobilization", Bone Marrow Transplant, 27(12), pp.1237~1243 (2001)
22. Gillgrass A., "Stimulating natural killer cells to protect against cancer : recent developments", Expert Rev Clin Immunol, 7(3), pp.367~382 (2011)
23. Shen Y., "Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer", Int J Oncol, 40(4), pp.1285~1290 (2012)
24. Konjevic G., "Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients", J BUON, 16(2), pp.219~226 (2011)
25. Boccaccio C., "The MET oncogene drives a genetic programme linking cancer to haemostasis", Nature, 434(7031), pp.396~400 (2005)
26. Rong Y., "PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma", Cancer Res, 65(4), pp.1406~1413 (2005)
27. Yu JL., "Oncogenic events regulate tissue factor expression in colorectal cancer cells : implications for tumor progression and angiogenesis", Blood, 105(4), pp.1734~1741 (2005)
28. Abe K., "Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor", Proc Natl Acad Sci U S A, 96(15), pp.8663~8668 (1999)
29. Belting M., "Regulation of angiogenesis by tissue factor cytoplasmic domain signaling", Nat Med, 10(5), pp.502~509 (2004)
30. Shoji M., "Activation of coagulation and angiogenesis in cancer : immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer", Am J Pathol, 152(2), pp.399~411 (1998)
31. Zhang Y., "Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice", J Clin Invest, 94(3), pp.1320~1327 (1994)
32. Contrino J., "In situ detection of tissue factor in vascular endothelial cells : correlation with the malignant phenotype of human breast disease", Nat Med, 2(2), pp.209~215 (1996)
33. Hair GA., "Tissue factor expression in human leukemic cells", Leuk Res, 20(1), pp.1~11 (1996)
34. Guan M., "Tissue factor expression and angiogenesis in human glioma", Clin Biochem, 35(4), pp.321~325 (2002)
35. Sawada M., "Expression of tissue factor in nonsmall- cell lung cancers and its relationship to metastasis", Br J Cancer, 79(3-4), pp.472~477 (1999)
36. Nakasaki T., "Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer", Am J Hematol, 69(4), pp.247~244 (2002)

관련 논문AI추천